Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Semaglutide Generics: Dr Reddy's, Sun, Alkem Set To Be Early Winners In $500 Million Obesity Market

    2 days ago

    According to an HSBC report, the entry of generics could unlock a $256 million to $512 million market opportunity, with early movers like Dr Reddy's Laboratories, Sun Pharma and Alkem Laboratories likely to be key beneficiaries.
    Click here to Read More
    Previous Article
    Eid Ul Fitr 2026 Moon Sighting Live Updates: When Will Saudi, UAE Witness Moon?
    Next Article
    IIFCL Recruitment 2026: Application Opens For 37 Vacancies — How To Apply?

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment